Statistical resolution of missing longitudinal data in clinical pharmacogenomics

Zhong Wang, Hongying Li, Jianxin Wang, Jiahan Li, Rongling Wu

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Clinical pharmacogenomics, integrating genomic information with clinical practices to facilitate the prediction of drug response, has recently emerged as a vital area of public health. In clinical trials, phenotypic data on drug response are often longitudinal, with some patients dropping out early due to physiological or other unpredictable reasons. The genetic analysis of such missing longitudinal data presents a significant challenge in clinical pharmacogenomics. We develop a statistical algorithm for detecting haplotypes that control longitudinal responses subject to non-ignorable dropout. The model was derived by incorporating the selection model into a dynamic model - functional mapping, aimed to discover genetic variants that contribute to phenotypic variation in longitudinal traits. The selection models is a statistical approach for analyzing missing longitudinal data by assuming that dropout depends on the outcome of drug response. The model derived can jointly characterize the genetic control of longitudinal responses and dropout events. Simulation studies were performed to investigate the statistical properties of the model and validate its practical usefulness. The model will find its implications for clinical pharmacogenomics toward personalized medicine.

Original languageEnglish (US)
Pages (from-to)980-986
Number of pages7
JournalAdvanced Drug Delivery Reviews
Volume65
Issue number7
DOIs
StatePublished - Jun 30 2013

Fingerprint

Pharmacogenetics
Pharmaceutical Preparations
Precision Medicine
Statistical Models
Haplotypes
Public Health
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Wang, Zhong ; Li, Hongying ; Wang, Jianxin ; Li, Jiahan ; Wu, Rongling. / Statistical resolution of missing longitudinal data in clinical pharmacogenomics. In: Advanced Drug Delivery Reviews. 2013 ; Vol. 65, No. 7. pp. 980-986.
@article{07b9d406123440869bf1bd3369b3d536,
title = "Statistical resolution of missing longitudinal data in clinical pharmacogenomics",
abstract = "Clinical pharmacogenomics, integrating genomic information with clinical practices to facilitate the prediction of drug response, has recently emerged as a vital area of public health. In clinical trials, phenotypic data on drug response are often longitudinal, with some patients dropping out early due to physiological or other unpredictable reasons. The genetic analysis of such missing longitudinal data presents a significant challenge in clinical pharmacogenomics. We develop a statistical algorithm for detecting haplotypes that control longitudinal responses subject to non-ignorable dropout. The model was derived by incorporating the selection model into a dynamic model - functional mapping, aimed to discover genetic variants that contribute to phenotypic variation in longitudinal traits. The selection models is a statistical approach for analyzing missing longitudinal data by assuming that dropout depends on the outcome of drug response. The model derived can jointly characterize the genetic control of longitudinal responses and dropout events. Simulation studies were performed to investigate the statistical properties of the model and validate its practical usefulness. The model will find its implications for clinical pharmacogenomics toward personalized medicine.",
author = "Zhong Wang and Hongying Li and Jianxin Wang and Jiahan Li and Rongling Wu",
year = "2013",
month = "6",
day = "30",
doi = "10.1016/j.addr.2013.03.003",
language = "English (US)",
volume = "65",
pages = "980--986",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "7",

}

Statistical resolution of missing longitudinal data in clinical pharmacogenomics. / Wang, Zhong; Li, Hongying; Wang, Jianxin; Li, Jiahan; Wu, Rongling.

In: Advanced Drug Delivery Reviews, Vol. 65, No. 7, 30.06.2013, p. 980-986.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Statistical resolution of missing longitudinal data in clinical pharmacogenomics

AU - Wang, Zhong

AU - Li, Hongying

AU - Wang, Jianxin

AU - Li, Jiahan

AU - Wu, Rongling

PY - 2013/6/30

Y1 - 2013/6/30

N2 - Clinical pharmacogenomics, integrating genomic information with clinical practices to facilitate the prediction of drug response, has recently emerged as a vital area of public health. In clinical trials, phenotypic data on drug response are often longitudinal, with some patients dropping out early due to physiological or other unpredictable reasons. The genetic analysis of such missing longitudinal data presents a significant challenge in clinical pharmacogenomics. We develop a statistical algorithm for detecting haplotypes that control longitudinal responses subject to non-ignorable dropout. The model was derived by incorporating the selection model into a dynamic model - functional mapping, aimed to discover genetic variants that contribute to phenotypic variation in longitudinal traits. The selection models is a statistical approach for analyzing missing longitudinal data by assuming that dropout depends on the outcome of drug response. The model derived can jointly characterize the genetic control of longitudinal responses and dropout events. Simulation studies were performed to investigate the statistical properties of the model and validate its practical usefulness. The model will find its implications for clinical pharmacogenomics toward personalized medicine.

AB - Clinical pharmacogenomics, integrating genomic information with clinical practices to facilitate the prediction of drug response, has recently emerged as a vital area of public health. In clinical trials, phenotypic data on drug response are often longitudinal, with some patients dropping out early due to physiological or other unpredictable reasons. The genetic analysis of such missing longitudinal data presents a significant challenge in clinical pharmacogenomics. We develop a statistical algorithm for detecting haplotypes that control longitudinal responses subject to non-ignorable dropout. The model was derived by incorporating the selection model into a dynamic model - functional mapping, aimed to discover genetic variants that contribute to phenotypic variation in longitudinal traits. The selection models is a statistical approach for analyzing missing longitudinal data by assuming that dropout depends on the outcome of drug response. The model derived can jointly characterize the genetic control of longitudinal responses and dropout events. Simulation studies were performed to investigate the statistical properties of the model and validate its practical usefulness. The model will find its implications for clinical pharmacogenomics toward personalized medicine.

UR - http://www.scopus.com/inward/record.url?scp=84879554063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879554063&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2013.03.003

DO - 10.1016/j.addr.2013.03.003

M3 - Review article

C2 - 23523630

AN - SCOPUS:84879554063

VL - 65

SP - 980

EP - 986

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 7

ER -